Program to Promote Engagement in Care for the Prevention of Recidivism

NCT ID: NCT04366466

Last Updated: 2020-04-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

138 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-05-31

Study Completion Date

2021-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In France, the number of emergency visits for suicide attempts is estimated at 220,000 per year. Suicide management aims to reduce suicide risk factors in order to improve the mental health of patients and prevent recurrences.

To day, no study has compared the approaches to health surveillance and case management in a clinical trial, nor established the benefit of each on commitment to care and beyond the prevention of suicidal recurrence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Suicide Health Care Seeking Behavior Case Management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Controlled, randomized and prospective study of a cohort of suicide victims comparing an experimental (interventional) group to a control group (usual treatment)
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

suicide attempt patient who will receive sanitory supervision

The control group will establish the health monitoring

Group Type OTHER

suicide attempt patient using PEPS Program

Intervention Type OTHER

The research protocol consists of two phases separated by randomization.

A Hospital Phase common to both groups:

Day zero is the day of the suicide attempt for which the patient came to the hospital.

A post-hospital phase including the P.E.P.S. program for the intervention group and telephone reminders for the usual treatment group.

Suicide attempt patient who will participate to PEPS Program

The intervention group will test the program of Promotion of Commitment to Care for the Prevention of Suicidal Recidivism.

Group Type EXPERIMENTAL

suicide attempt patient using PEPS Program

Intervention Type OTHER

The research protocol consists of two phases separated by randomization.

A Hospital Phase common to both groups:

Day zero is the day of the suicide attempt for which the patient came to the hospital.

A post-hospital phase including the P.E.P.S. program for the intervention group and telephone reminders for the usual treatment group.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

suicide attempt patient using PEPS Program

The research protocol consists of two phases separated by randomization.

A Hospital Phase common to both groups:

Day zero is the day of the suicide attempt for which the patient came to the hospital.

A post-hospital phase including the P.E.P.S. program for the intervention group and telephone reminders for the usual treatment group.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Suicide attempt patient using sanitary supervision

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18.
* Male and female.
* Admission to CH St Denis for a suicide attempt.
* Referral for outpatient follow-up.
* Patient with no psychiatric follow-up or who has been out of follow-up for at least three months.
* Patient having given their written informed consent.

Exclusion Criteria

* Patients not affiliated with social security or state medical aid.
* Patients who do not have the required faculties to be evaluated (cognitive and delusional disorders).
* Patients treated for more than 72 hours after their procedure (maximum length of stay in the UAS and/or in medical intensive care.
* Patient currently under psychiatric care.
* Patients who cannot be called back by telephone (no telephone, homeless, incarceration).
* Patients who do not master the French language.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Januel

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Januel

Head of clinical research unit

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Fayçal MOUAFFAK

Role: PRINCIPAL_INVESTIGATOR

Investigateur Principal

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Youcef BENCHERIF

Role: CONTACT

Phone: 01.43.09.32.32

Email: [email protected]

Rusheenthira THAVASEELAN

Role: CONTACT

Phone: 0143.0932.32

Email: [email protected]

References

Explore related publications, articles, or registry entries linked to this study.

Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2.

Reference Type DERIVED
PMID: 33884617 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

10477M-PEPS

Identifier Type: -

Identifier Source: org_study_id